Nicholas Conrad Smith
CIK: 0002009130
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Alto Neuroscience, Inc.
Discretionary Trading P&L
Holdings
Transaction History (20 total)
- Oct 2, 2026ANRO
Alto Neuroscience, Inc.
Exercise(M)Direct55K shares at avg. $2.32$128K - Sep 30, 2026ANRO
Alto Neuroscience, Inc.
Sale(S)Direct886 shares at avg. $26.87$24K - Sep 30, 2026ANRO
Alto Neuroscience, Inc.
Exercise(M)Direct24.1K shares at avg. $2.35$57K - Sep 30, 2026ANRO
Alto Neuroscience, Inc.
Sale(S)Direct23.2K shares at avg. $25.78$597K - Sep 29, 2026ANRO
Alto Neuroscience, Inc.
Sale(S)Direct110.8K shares at avg. $26.58$2.9M - Sep 29, 2026ANRO
Alto Neuroscience, Inc.
Exercise(M)Direct56.5K shares at avg. $2.35$133K - Sep 29, 2026ANRO
Alto Neuroscience, Inc.
Exercise(M)Direct54.4K shares at avg. $2.35$128K - Mar 1, 2026ANRO
Alto Neuroscience, Inc.
Tax Payment(F)Direct2.8K shares at avg. $19.69$55K - Feb 11, 2026ANRO
Alto Neuroscience, Inc.
Award(A)DirectEmployee Stock Option (Right to Buy)
200K shares- - Jul 3, 2025ANRO
Alto Neuroscience, Inc.
Award(A)DirectEmployee Stock Option (Right to Buy)
45K shares- - Jul 3, 2025ANRO
Alto Neuroscience, Inc.
Award(A)DirectEmployee Stock Option (Right to Buy)
33.8K shares- - Jul 3, 2025ANRO
Alto Neuroscience, Inc.
Disposition(D)DirectEmployee Stock Option (Right to Buy)
33.8K shares- - Jul 3, 2025ANRO
Alto Neuroscience, Inc.
Award(A)DirectEmployee Stock Option (Right to Buy)
202.3K shares- - Jul 3, 2025ANRO
Alto Neuroscience, Inc.
Disposition(D)DirectEmployee Stock Option (Right to Buy)
202.3K shares- - Jul 3, 2025ANRO
Alto Neuroscience, Inc.
Award(A)DirectEmployee Stock Option (Right to Buy)
90K shares- - Jul 3, 2025ANRO
Alto Neuroscience, Inc.
Disposition(D)DirectEmployee Stock Option (Right to Buy)
90K shares- - Jul 3, 2025ANRO
Alto Neuroscience, Inc.
Award(A)DirectEmployee Stock Option (Right to Buy)
135K shares- - Jul 3, 2025ANRO
Alto Neuroscience, Inc.
Disposition(D)DirectEmployee Stock Option (Right to Buy)
135K shares- - Jul 3, 2025ANRO
Alto Neuroscience, Inc.
Disposition(D)DirectEmployee Stock Option (Right to Buy)
45K shares- - Feb 5, 2025ANRO
Alto Neuroscience, Inc.
Award(A)DirectEmployee Stock Option (Right to Buy)
135K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 2, 2026 | ANRO Alto Neuroscience, Inc. | Exercise(M) | 55,000 | $2.32 | $127,600 | Direct |
| Sep 30, 2026 | ANRO Alto Neuroscience, Inc. | Sale(S) | 886 | $26.87 | $23,807 | Direct |
| Sep 30, 2026 | ANRO Alto Neuroscience, Inc. | Exercise(M) | 24,056 | $2.35 | $56,532 | Direct |
| Sep 30, 2026 | ANRO Alto Neuroscience, Inc. | Sale(S) | 23,170 | $25.78 | $597,290 | Direct |
| Sep 29, 2026 | ANRO Alto Neuroscience, Inc. | Sale(S) | 110,830 | $26.58 | $2,946,150 | Direct |
| Sep 29, 2026 | ANRO Alto Neuroscience, Inc. | Exercise(M) | 56,455 | $2.35 | $132,669 | Direct |
| Sep 29, 2026 | ANRO Alto Neuroscience, Inc. | Exercise(M) | 54,375 | $2.35 | $127,781 | Direct |
| Mar 1, 2026 | ANRO Alto Neuroscience, Inc. | Tax Payment(F) | 2,806 | $19.69 | $55,250 | Direct |
| Feb 11, 2026 | ANRO Alto Neuroscience, Inc. | Award(A) Employee Stock Option (Right to Buy) | 200,000 | - | - | Direct |
| Jul 3, 2025 | ANRO Alto Neuroscience, Inc. | Award(A) Employee Stock Option (Right to Buy) | 44,962 | - | - | Direct |
| Jul 3, 2025 | ANRO Alto Neuroscience, Inc. | Award(A) Employee Stock Option (Right to Buy) | 33,833 | - | - | Direct |
| Jul 3, 2025 | ANRO Alto Neuroscience, Inc. | Disposition(D) Employee Stock Option (Right to Buy) | 33,833 | - | - | Direct |
| Jul 3, 2025 | ANRO Alto Neuroscience, Inc. | Award(A) Employee Stock Option (Right to Buy) | 202,329 | - | - | Direct |
| Jul 3, 2025 | ANRO Alto Neuroscience, Inc. | Disposition(D) Employee Stock Option (Right to Buy) | 202,329 | - | - | Direct |
| Jul 3, 2025 | ANRO Alto Neuroscience, Inc. | Award(A) Employee Stock Option (Right to Buy) | 90,000 | - | - | Direct |
| Jul 3, 2025 | ANRO Alto Neuroscience, Inc. | Disposition(D) Employee Stock Option (Right to Buy) | 90,000 | - | - | Direct |
| Jul 3, 2025 | ANRO Alto Neuroscience, Inc. | Award(A) Employee Stock Option (Right to Buy) | 135,000 | - | - | Direct |
| Jul 3, 2025 | ANRO Alto Neuroscience, Inc. | Disposition(D) Employee Stock Option (Right to Buy) | 135,000 | - | - | Direct |
| Jul 3, 2025 | ANRO Alto Neuroscience, Inc. | Disposition(D) Employee Stock Option (Right to Buy) | 44,962 | - | - | Direct |
| Feb 5, 2025 | ANRO Alto Neuroscience, Inc. | Award(A) Employee Stock Option (Right to Buy) | 135,000 | - | - | Direct |
1-20 of 20 transactions
About Smith Nicholas Conrad
Smith Nicholas Conrad (SEC CIK 0002009130) files insider reports with the SEC as PRESIDENT AND CFO of Alto Neuroscience, Inc. (ANRO).
Signal8 holds 6 ownership filings by Smith Nicholas Conrad, all Form 4s, filed between Feb 7, 2025 and Oct 5, 2026. Those filings report 20 transactions, from Feb 5, 2025 to Oct 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Smith Nicholas Conrad's filings is in MOUNTAIN VIEW, CA.
Recent filings by Smith Nicholas Conrad
- Oct 2, 2026: Option exercise of ANRO shares (Form 4, code M).
- Sep 30, 2026: Open-market sale of ANRO shares (Form 4, code S).
- Sep 30, 2026: Option exercise of ANRO shares (Form 4, code M).
- Sep 30, 2026: Open-market sale of ANRO shares (Form 4, code S).
- Sep 29, 2026: Open-market sale of ANRO shares (Form 4, code S).
Other insiders filing for Alto Neuroscience, Inc. (ANRO)
- Miller Andrew Craig, Director
- Etkin Amit, PRESIDENT AND CEO
- Sanchez Ramiro, Director
- Cox Christopher Nixon, Director
- Manji Husseini, Director
- Dreyfus Andrew, Director